slotkoers
Korea S.E.
00:00:00 21-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3.375
KRW
|
-3,02%
|
|
-6,25%
|
-9,27%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
111.350
|
149.114
|
230.984
|
199.665
|
159.505
|
99.724
|
Bedrijfswaarde
1 |
105.832
|
139.679
|
216.755
|
179.193
|
135.980
|
78.118
|
K/w-verhouding
|
32,9
x
|
26
x
|
84,1
x
|
27,3
x
|
34,2
x
|
-27,1
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
4,32
x
|
5,68
x
|
7,85
x
|
5,58
x
|
4,53
x
|
3,72
x
|
Bedrijfswaarde/omzet
|
4,1
x
|
5,32
x
|
7,36
x
|
5,01
x
|
3,86
x
|
2,91
x
|
Bedrijfswaarde/EBITDA
|
19,7
x
|
25,2
x
|
37,1
x
|
22,7
x
|
19,9
x
|
245
x
|
Bedrijfswaarde/FCF
|
-116
x
|
268
x
|
62,2
x
|
26
x
|
-113
x
|
-40,1
x
|
FCF Yield
|
-0,86%
|
0,37%
|
1,61%
|
3,85%
|
-0,89%
|
-2,49%
|
Price to Book
|
3,17
x
|
3,63
x
|
5,08
x
|
3,81
x
|
2,77
x
|
1,86
x
|
Aantal aandelen (in duizenden)
|
26.293
|
26.533
|
26.796
|
26.801
|
26.808
|
26.808
|
Referentieprijs
2 |
4.235
|
5.620
|
8.620
|
7.450
|
5.950
|
3.720
|
Datum van publicatie
|
11/03/19
|
10/03/20
|
17/03/21
|
16/03/22
|
23/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
25.797
|
26.256
|
29.443
|
35.784
|
35.201
|
26.837
|
EBITDA
1 |
5.384
|
5.544
|
5.837
|
7.890
|
6.823
|
319
|
Bedrijfsresultaat (EBIT)
1 |
2.826
|
3.051
|
3.403
|
5.236
|
4.381
|
-2.229
|
Operationele Marge
|
10,95%
|
11,62%
|
11,56%
|
14,63%
|
12,45%
|
-8,31%
|
Resultaat voor belastingen (EBT)
1 |
3.354
|
4.276
|
2.115
|
5.470
|
5.508
|
-1.205
|
Nettowinst (verlies)
1 |
3.308
|
5.750
|
2.737
|
7.321
|
4.665
|
-3.678
|
Nettomarge
|
12,82%
|
21,9%
|
9,29%
|
20,46%
|
13,25%
|
-13,71%
|
WPA
2 |
128,6
|
216,0
|
102,5
|
273,0
|
174,0
|
-137,2
|
Free Cash Flow
1 |
-910
|
521,5
|
3.485
|
6.897
|
-1.204
|
-1.948
|
FCF-marge
|
-3,53%
|
1,99%
|
11,84%
|
19,27%
|
-3,42%
|
-7,26%
|
Kasstroomconversie (ebitda)
|
-
|
9,41%
|
59,7%
|
87,41%
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
9,07%
|
127,34%
|
94,22%
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
11/03/19
|
10/03/20
|
17/03/21
|
16/03/22
|
23/03/23
|
20/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
5.518
|
9.435
|
14.229
|
20.471
|
23.525
|
21.607
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-910
|
521
|
3.485
|
6.897
|
-1.204
|
-1.948
|
ROE (netto-inkomsten/eigen vermogen)
|
11,2%
|
15,1%
|
6,33%
|
15%
|
8,48%
|
-6,61%
|
ROA (netto-inkomsten/totale activa)
|
4,18%
|
4,3%
|
4,28%
|
5,68%
|
4,36%
|
-2,29%
|
Totale activa
1 |
79.167
|
133.875
|
63.981
|
128.924
|
107.106
|
160.846
|
Nettoactief per aandeel
2 |
1.337
|
1.546
|
1.698
|
1.953
|
2.150
|
1.999
|
Cashflow per aandeel
2 |
260,0
|
369,0
|
256,0
|
487,0
|
600,0
|
221,0
|
Capex
1 |
537
|
841
|
1.081
|
2.560
|
4.001
|
1.240
|
Capex/omzet
|
2,08%
|
3,2%
|
3,67%
|
7,15%
|
11,37%
|
4,62%
|
Datum van publicatie
|
11/03/19
|
10/03/20
|
17/03/21
|
16/03/22
|
23/03/23
|
20/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -9,27% | 77,96 mln. | | -52,23% | 2,36 mld. | | +23,01% | 1,94 mld. | | -10,06% | 1,5 mld. | | +21,24% | 1,23 mld. | | -23,46% | 880 mln. | | +1,33% | 782 mln. | | -34,13% | 752 mln. | | +23,58% | 593 mln. | | -29,66% | 589 mln. |
Medisch diagnose- & testmateriaal
|